The suppressive effect of myeloid elf-1-like factor (MEF) in osteogenic differentiation

Journal of Cellular Physiology

Volumn 211, Issue 1, 2007, Pages 253-260

  Kim, Youn Jeong ^a   Kim, Byung Gyu ^a   Lee, Seung Jin ^a   Lee, Ho Kyung ^a   Lee, Sang Han ^a   Ryoo, Hyun Mo ^b   Cho, Je Yoel ^a  

^a Kyungpook National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; LUCIFERASE; MESSENGER RNA; MYELOID ELF 1 LIKE FACTOR; OSTEOCALCIN; PROTEIN MAB21L1; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN; COMPLEX FORMATION; CONTROLLED STUDY; DEVELOPMENTAL GENE; DEVELOPMENTAL GENETICS; ENZYME REPRESSION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSE2 GENE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REPORTER GENE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, REPORTER; HUMANS; LUCIFERASES; MICE; OSTEOCALCIN; OSTEOGENESIS; PROTEIN BINDING; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847648883     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20933     Document Type: Article

References (44)

1. Acampora D, Merlo GR, Paleari L, Zerega B, Postiglione MP, Mantero S, Bober E, Barbieri O, Simeone A, Levi G. 1999. Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development 126:3795-3809.
2. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M. Ito Y. 1993. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809-614.
3. Baldessari D, Badaloni A, Longhi R, Zappavigna V, Consalez GG. 2004. MAB21L2, a vertebrate member of the male-abnormal 21 family, modulates BMP signaling and interacts with SMAD1. BMC Cell Biol 5:48.
4. Bassuk AG, Leiden JM. 1997. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv Immunol 64:65-104.
5. Bidder M, Latifi T, Towler DA. 1998. Reciprocal temporospatial patterns of Msx2 and Osteocalcin gene expression during murine odontogenesis. J Bone Miner Res 13:609-619.
6. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
7. Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, van Wijnen AJ, Stein GS, Stein JL, Lian JB. 2004. Dlx3 transcriptional regulation of osteoblast differentiation: Temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24:9248-9261.
8. Hedvat CV, Yao J, Sokolic RA, Nimer SD. 2004. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 279:6395-6400.
9. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, Hisada K, Yatani H, Cao X, Komori T, Yamaguchi A, Yoneda T. 2004. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem 279:34015-34022.
10. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 64:4808-4819.
11. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. 2003. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
12. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. 2004. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279:50773-50780.
13. Kiyoshima T, Yamauchi M, Wong C, Jheon A, Ganss B, Sodek J. 2002. An L1 element disrupts human bone sialoprotein promoter: Lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a I (Cbfa1) elements. Gene 299:205-217.
14. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
15. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM. 1999. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta I in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73:114-125.
16. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM. 2003. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta I opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278:34387-34394.
17. Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM. 2005. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280:35579-35587.
18. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D. 1983. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306:395-397.
19. Lindemann RK, Ballschmieter P, Nordheim A, Dittmer J. 2001. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J Biol Chem 276:46661-46670.
20. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MA Jr, Snead ML, Maxson RE Jr. 1995. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci USA 92:6137-6141.
21. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE. 1999. Msx2 gene dosage influences the number of proliferative osteogenic cells ingrowth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205:260-274.
22. Lu Z, Kim KA, Suico MA, Shuto T, Li JD, Kai H. 2004. MEF up-regulates human beta-defensin 2 expression in epithelial cells. FEBS Lett 561:117-121.
23. Mao S, Frank RC, Zhang J, Miyazaki Y, Nimer SD. 1999. Functional and physical interactions between AML1 proteins and an ETS protein. MEF: Implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol 19:3635-3644.
24. Mariani M, Baldessari D, Francisconi S, Viggiano L, Rocchi M, Zappavigna V, Malgaretti N, Consalez GG. 1999. Two murine and human homologs of mab-21, a cell fate determination gene involved in Caenorhabditis elegans neural development. Hum Mol Genet 8:2397-2406.
25. Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. 1996. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 13:1721-1729.
26. Miyazaki Y, Boccuni P, Mao S, Zhang J, Erdjument-Bromage H, Tempst P, Kiyokawa H, Nimer SD. 2001. Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle. J Biol Chem 276:40528-40536.
27. Newberry EP, Latifi T, Towler DA. 1998. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37:16360-16368.
28. Oikawa T. 2004. ETS transcription factors: Possible targets for cancer therapy. Cancer Sci 95:626-633.
29. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
30. Postigo AA, Depp JL, Taylor JJ, Kroll KL. 2003. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. Embo J 22:2453-2462.
31. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi JY, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ. 2003. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63:5357-5362.
32. Raouf A, Seth A. 2000. Ets transcription factors and targets in osteogenesis. Oncogene 19:6455-6463.
33. Robledo RF, Rajan L, Li X, Lufkin T. 2002. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-1101.
34. Roca H, Phimphilai M, Gopalakrishnan R, Xiao G, Franceschi RT. 2005. Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene. J Biol Chem 280:30845-30855.
35. Sato M, Morii E, Komori T, Kawahata H. Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
36. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R. 2000. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24:391-395.
37. Seki Y, Suico MA, Uto A, Hisatsune A, Shuto T, Isohama Y, Kai H. 2002. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Cancer Res 62:6579-6586.
38. Shirakabe K, Terasawa K, Miyama K, Shibuya H, Nishida E. 2001. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6:851-856.
39. Suico MA, Koyanagi T, Ise S, Lu Z, Hisatsune A, Seki Y, Shuto T, Isohama Y, Miyata T, Kai H. 2002. Functional dissection of the ETS transcription factor MEF. Biochim Biophys Acta 1577:113-120.
40. Tadic T, Erceg I, Stover ML, Rowe DW, Lichtler AC. 2001. Dlx5 induces expression of COL1A1 promoter contained in a retrovirus vector. Croat Med J 42:436-439.
41. Towler DA, Bennett CD, Rodan GA. 1994a. Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CPI binding motifs. Mol Endocrinol 8:614-624.
42. Towler DA, Rutledge SJ, Rodan GA. 1994b. Msx-2/Hox 8.1: A transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 8:1484-1493.
43. Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A. 1997. FLII and EWS-FLII function as ternary complex factors and ELKI and SAPI a function as ternary and quaternary complex factors on the EgH promoter serum response elements. Oncogene 14:213-221.
44. Wijmenga C, Speck NA, Dracopoli NC, Hofker MH, Liu P, Collins FS. 1995. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome Ip35-pter. Genomics 26:611-614.